These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

553 related items for PubMed ID: 24361777

  • 21. [N-terminal pro-B-type natriuretic peptide value for prediction of mortality among critically ill patients in different age groups in intensive care unit].
    Li H, Wang H, Lou Y, Miao W, Sha N.
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Jul; 26(7):508-12. PubMed ID: 25027431
    [Abstract] [Full Text] [Related]

  • 22. Amino-terminal pro-B-type natriuretic peptide testing for inpatient monitoring and treatment guidance of acute destabilized heart failure.
    Bettencourt P, Januzzi JL.
    Am J Cardiol; 2008 Feb 04; 101(3A):67-71. PubMed ID: 18243862
    [Abstract] [Full Text] [Related]

  • 23. Pro-A-type natriuretic peptide, proadrenomedullin, and N-terminal pro-B-type natriuretic peptide used in a multimarker strategy in primary health care in risk assessment of patients with symptoms of heart failure.
    Alehagen U, Dahlström U, Rehfeld JF, Goetze JP.
    J Card Fail; 2013 Jan 04; 19(1):31-9. PubMed ID: 23273592
    [Abstract] [Full Text] [Related]

  • 24. Design and methods of the Pro-B Type Natriuretic Peptide Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study.
    Bhardwaj A, Rehman SU, Mohammed A, Baggish AL, Moore SA, Januzzi JL.
    Am Heart J; 2010 Apr 04; 159(4):532-538.e1. PubMed ID: 20362709
    [Abstract] [Full Text] [Related]

  • 25. Rationale and design of the ICON-RELOADED study: International Collaborative of N-terminal pro-B-type Natriuretic Peptide Re-evaluation of Acute Diagnostic Cut-Offs in the Emergency Department.
    Gaggin HK, Chen-Tournoux AA, Christenson RH, Doros G, Hollander JE, Levy PD, Nagurney JT, Nowak RM, Pang PS, Patel D, Peacock WF, Walters EL, Januzzi JL, ICON-RELOADED Investigators.
    Am Heart J; 2017 Oct 04; 192():26-37. PubMed ID: 28938961
    [Abstract] [Full Text] [Related]

  • 26. Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population.
    Lam CS, Burnett JC, Costello-Boerrigter L, Rodeheffer RJ, Redfield MM.
    J Am Coll Cardiol; 2007 Mar 20; 49(11):1193-202. PubMed ID: 17367664
    [Abstract] [Full Text] [Related]

  • 27. Role of the plasma brain natriuretic peptide in differentiating patients with congestive heart failure from other diseases.
    Sirithunyanont C, Leowattana W, Sukumalchantra Y, Chaisupamonkollarp S, Watanawaroon S, Chivatanaporn B, Bhuripanyo K, Mahanonda N.
    J Med Assoc Thai; 2003 May 20; 86 Suppl 1():S87-95. PubMed ID: 12866774
    [Abstract] [Full Text] [Related]

  • 28. Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in cats.
    Fox PR, Oyama MA, Reynolds C, Rush JE, DeFrancesco TC, Keene BW, Atkins CE, Macdonald KA, Schober KE, Bonagura JD, Stepien RL, Kellihan HB, Nguyenba TP, Lehmkuhl LB, Lefbom BK, Moise NS, Hogan DF.
    J Vet Cardiol; 2009 May 20; 11 Suppl 1():S51-61. PubMed ID: 19394287
    [Abstract] [Full Text] [Related]

  • 29. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.
    Anwaruddin S, Lloyd-Jones DM, Baggish A, Chen A, Krauser D, Tung R, Chae C, Januzzi JL.
    J Am Coll Cardiol; 2006 Jan 03; 47(1):91-7. PubMed ID: 16386670
    [Abstract] [Full Text] [Related]

  • 30. Use of N-terminal prohormone brain natriuretic peptide assay for etiologic diagnosis of acute dyspnea in elderly patients.
    Berdagué P, Caffin PY, Barazer I, Vergnes C, Sedighian S, Letrillard S, Pilossof R, Goutorbe F, Piot C, Reny JL.
    Am Heart J; 2006 Mar 03; 151(3):690-8. PubMed ID: 16504634
    [Abstract] [Full Text] [Related]

  • 31. Usefulness of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide as biomarkers for heart failure in young children with single ventricle congenital heart disease.
    Lowenthal A, Camacho BV, Lowenthal S, Natal-Hernandez L, Liszewski W, Hills NK, Fineman JR, Bernstein HS.
    Am J Cardiol; 2012 Mar 15; 109(6):866-72. PubMed ID: 22196786
    [Abstract] [Full Text] [Related]

  • 32. Amino-terminal pro-B-type natriuretic peptides and prognosis in chronic heart failure.
    Masson S, Latini R.
    Am J Cardiol; 2008 Feb 04; 101(3A):56-60. PubMed ID: 18243860
    [Abstract] [Full Text] [Related]

  • 33. Comparison of pleural N-terminal pro-B-type natriuretic peptide, midregion pro-atrial natriuretic peptide and mid-region pro-adrenomedullin for the diagnosis of pleural effusions associated with cardiac failure.
    Porcel JM, Bielsa S, Morales-Rull JL, Civit C, Cao G, Light RW, Esquerda A.
    Respirology; 2013 Apr 04; 18(3):540-5. PubMed ID: 23278975
    [Abstract] [Full Text] [Related]

  • 34. [Value of plasma NT-proBNP for diagnosing heart failure in patients with previous myocardial infarction].
    Wei BQ, Zhang J, Yang YJ, Lü R, Zhang YH, Zhou Q, Gao RL.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Jan 04; 40(1):34-8. PubMed ID: 22490631
    [Abstract] [Full Text] [Related]

  • 35. NT-proBNP concentrations indicate cardiac disease in pediatric patients.
    Geiger R, Hammerer-Lercher A, Url C, Schweigmann U, Puschendorf B, Sommer R, Stein JI, Mair J.
    Int J Cardiol; 2007 Dec 15; 123(1):63-5. PubMed ID: 17289184
    [Abstract] [Full Text] [Related]

  • 36. [Prognostic value of N-terminal-pro-brain natriuretic peptide on admission in patients with chronic heart failure].
    Wang F, Li W, Huang J, Wang L, Bian WY, Pang HM, Wang Y, Xu ZM, Li YS.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jan 15; 34(1):28-32. PubMed ID: 16626545
    [Abstract] [Full Text] [Related]

  • 37. The role of N-terminal pro-B-type natriuretic peptide in the diagnosis of congestive heart failure in children. - Correlation with the heart failure score and comparison with B-type natriuretic peptide -.
    Sugimoto M, Manabe H, Nakau K, Furuya A, Okushima K, Fujiyasu H, Kakuya F, Goh K, Fujieda K, Kajino H.
    Circ J; 2010 May 15; 74(5):998-1005. PubMed ID: 20378998
    [Abstract] [Full Text] [Related]

  • 38. Amino-terminal pro-B-type natriuretic peptide testing and prognosis in patients with acute dyspnea, including those with acute heart failure.
    Baggish AL, van Kimmenade RR, Januzzi JL.
    Am J Cardiol; 2008 Feb 04; 101(3A):49-55. PubMed ID: 18243859
    [Abstract] [Full Text] [Related]

  • 39. Rapid point-of-care NT-proBNP optimal cut-off point for heart failure diagnosis in primary care.
    Verdú JM, Comín-Colet J, Domingo M, Lupón J, Gómez M, Molina L, Casacuberta JM, Muñoz MA, Mena A, Bruguera-Cortada J.
    Rev Esp Cardiol (Engl Ed); 2012 Jul 04; 65(7):613-9. PubMed ID: 22541282
    [Abstract] [Full Text] [Related]

  • 40. A validated clinical and biochemical score for the diagnosis of acute heart failure: the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Acute Heart Failure Score.
    Baggish AL, Siebert U, Lainchbury JG, Cameron R, Anwaruddin S, Chen A, Krauser DG, Tung R, Brown DF, Richards AM, Januzzi JL.
    Am Heart J; 2006 Jan 04; 151(1):48-54. PubMed ID: 16368291
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.